SEHK:1931

Stock Analysis Report

Executive Summary

IVD Medical Holding Limited distributes in vitro diagnostic (IVD) products in the People's Republic of China.

Snowflake

Fundamentals

Excellent balance sheet and fair value.

Share Price & News

How has IVD Medical Holding's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 1931 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

2.2%

1931

-2.2%

HK Healthcare

-1.9%

HK Market


1 Year Return

n/a

1931

-27.9%

HK Healthcare

1.0%

HK Market

Return vs Industry: Insufficient data to determine how 1931 performed against the Hong Kong Healthcare industry.

Return vs Market: Insufficient data to determine how 1931 performed against the Hong Kong Market.


Shareholder returns

1931IndustryMarket
7 Day2.2%-2.2%-1.9%
30 Day6.0%4.4%2.3%
90 Day7.0%8.6%7.4%
1 Yearn/a-26.3%-27.9%4.7%1.0%
3 Yearn/a-26.7%-31.1%22.6%10.3%
5 Yearn/a-31.5%-37.4%21.5%1.3%

Price Volatility Vs. Market

How volatile is IVD Medical Holding's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is IVD Medical Holding undervalued compared to its fair value and its price relative to the market?

5.34x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate 1931's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate 1931's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 1931 is good value based on its PE Ratio (5.3x) compared to the Healthcare industry average (16.4x).

PE vs Market: 1931 is good value based on its PE Ratio (5.3x) compared to the Hong Kong market (10.4x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 1931's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 1931 is good value based on its PB Ratio (1.4x) compared to the HK Healthcare industry average (1.5x).


Next Steps

Future Growth

How is IVD Medical Holding forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

-14.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1931's earnings are forecast to decline over the next 3 years (-14.6% per year).

Earnings vs Market: 1931's earnings are forecast to decline over the next 3 years (-14.6% per year).

High Growth Earnings: 1931's earnings are forecast to decline over the next 3 years.

Revenue vs Market: Insufficient data to determine if 1931's revenue is forecast to grow faster than the Hong Kong market.

High Growth Revenue: Insufficient data to determine if 1931's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 1931's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has IVD Medical Holding performed over the past 5 years?

272.1%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: 1931 has large one-off items impacting its financial results.

Growing Profit Margin: 1931's current net profit margins (36.4%) are higher than last year (30.5%).


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if 1931's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare 1931's past year earnings growth to its 5-year average.

Earnings vs Industry: 1931 earnings growth over the past year (272.1%) exceeded the Healthcare industry 7.2%.


Return on Equity

High ROE: 1931's Return on Equity (20.4%) is considered high.


Return on Assets


Return on Capital Employed


Next Steps

Financial Health

How is IVD Medical Holding's financial position?


Financial Position Analysis

Short Term Liabilities: 1931's short term assets (CN¥1.6B) exceeds its short term liabilities (CN¥1.1B)

Long Term Liabilities: 1931's short term assets (1.6B) exceeds its long term liabilities (202.5M)


Debt to Equity History and Analysis

Debt Level: 1931's debt to equity ratio (5.4%) is considered satisfactory

Reducing Debt: Insufficient data to determine if 1931's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 1931's debt is well covered by operating cash flow (25.3%).

Interest Coverage: 1931's interest payments on its debt are well covered by EBIT (133.6x coverage).


Balance Sheet

Inventory Level: 1931 has a high level of physical assets or inventory.

Debt Coverage by Assets: 1931's debt is covered by short term assets (assets are 14.5x debt).


Next Steps

Dividend

What is IVD Medical Holding's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%2.2%markettop25%6.3%industryaverage2.5%forecastin3Yearsn/a

Current dividend yield vs market & industry

Notable Dividend: Unable to evaluate 1931's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 1931's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 1931's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1931's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 1931's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

What is the CEO of IVD Medical Holding's salary, the management and board of directors tenure and is there insider trading?


CEO

Kuk Sing Ho 0

0yrs

Tenure

0

Mr. Kuk Sing Ho serves as a Chairman, Chief Executive Officer and Executive Director at IVD Medical Holding Limited. 


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.8%.


Management Team

  • Kuk Sing Ho

    Chairman

    • Tenure: 0yrs
  • King Sun Leung

    Chief Operating Officer and Executive Director

    • Tenure: 0yrs

Board Members

  • Kuk Sing Ho

    Chairman

    • Tenure: 0yrs
  • Xianya Lin

    Executive Director

    • Tenure: 0yrs
  • King Sun Leung

    Chief Operating Officer and Executive Director

    • Tenure: 0yrs

Company Information

IVD Medical Holding Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: IVD Medical Holding Limited
  • Ticker: 1931
  • Exchange: SEHK
  • Founded: 1993
  • Industry: Health Care Distributors
  • Sector: Healthcare
  • Market Cap: HK$4.160b
  • Shares outstanding: 1.33b
  • Website: https://www.ivdholding.com

Number of Employees


Location

  • IVD Medical Holding Limited
  • Building 6
  • Room 602
  • Shanghai
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
1931SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDJul 2019

Biography

IVD Medical Holding Limited distributes in vitro diagnostic (IVD) products in the People's Republic of China. The company operates through Distribution Business and Self-branded Products Business segments. ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/11/12 12:54
End of Day Share Price2019/11/12 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.